JP6914256B2 - 膵臓脂肪浸潤を予防または治療し、膵臓脂肪浸潤に起因する膵臓病変、糖尿病または他の関連症状を緩和するための組成物、および方法 - Google Patents

膵臓脂肪浸潤を予防または治療し、膵臓脂肪浸潤に起因する膵臓病変、糖尿病または他の関連症状を緩和するための組成物、および方法 Download PDF

Info

Publication number
JP6914256B2
JP6914256B2 JP2018526113A JP2018526113A JP6914256B2 JP 6914256 B2 JP6914256 B2 JP 6914256B2 JP 2018526113 A JP2018526113 A JP 2018526113A JP 2018526113 A JP2018526113 A JP 2018526113A JP 6914256 B2 JP6914256 B2 JP 6914256B2
Authority
JP
Japan
Prior art keywords
pancreatic
combination
mannitol
eriodictyol
menthol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018526113A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019511996A5 (enExample
JP2019511996A (ja
Inventor
幼圃 胡
幼圃 胡
欣恬 何
欣恬 何
永恩 呉
永恩 呉
熙卉 唐
熙卉 唐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Education Foundation
Original Assignee
International Education Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Education Foundation filed Critical International Education Foundation
Publication of JP2019511996A publication Critical patent/JP2019511996A/ja
Publication of JP2019511996A5 publication Critical patent/JP2019511996A5/ja
Application granted granted Critical
Publication of JP6914256B2 publication Critical patent/JP6914256B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
JP2018526113A 2015-11-19 2016-11-21 膵臓脂肪浸潤を予防または治療し、膵臓脂肪浸潤に起因する膵臓病変、糖尿病または他の関連症状を緩和するための組成物、および方法 Active JP6914256B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562257707P 2015-11-19 2015-11-19
US62/257,707 2015-11-19
PCT/CN2016/106607 WO2017084631A1 (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法

Publications (3)

Publication Number Publication Date
JP2019511996A JP2019511996A (ja) 2019-05-09
JP2019511996A5 JP2019511996A5 (enExample) 2020-01-09
JP6914256B2 true JP6914256B2 (ja) 2021-08-04

Family

ID=58717399

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018526113A Active JP6914256B2 (ja) 2015-11-19 2016-11-21 膵臓脂肪浸潤を予防または治療し、膵臓脂肪浸潤に起因する膵臓病変、糖尿病または他の関連症状を緩和するための組成物、および方法

Country Status (12)

Country Link
US (1) US20180325840A1 (enExample)
EP (1) EP3378481B1 (enExample)
JP (1) JP6914256B2 (enExample)
CN (3) CN109715170A (enExample)
DK (1) DK3378481T3 (enExample)
ES (1) ES2949047T3 (enExample)
FI (1) FI3378481T3 (enExample)
HU (1) HUE062181T2 (enExample)
PL (1) PL3378481T3 (enExample)
PT (1) PT3378481T (enExample)
TW (1) TWI797068B (enExample)
WO (1) WO2017084631A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110269855A (zh) * 2019-07-19 2019-09-24 辽宁大学 黄酮类小分子化合物在制备抑制胰脂肪酶活性药物中的应用
JP2021161070A (ja) * 2020-03-31 2021-10-11 花王株式会社 Ｇｌｐ−１分泌促進剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
CN1840518A (zh) * 2005-08-18 2006-10-04 山东寻山水产集团有限公司 一种从海带中提取甘露醇的方法
JP2008007452A (ja) * 2006-06-28 2008-01-17 Ajinomoto Co Inc 膵β細胞保護剤
CN1911114B (zh) * 2006-08-25 2012-08-15 李罡 一种含三氯蔗糖的饮料
EP1925311A1 (en) * 2006-11-15 2008-05-28 Melbrosin International Produktions und Vertriebs GmbH & Co KG Use of a plant extract or plant juice
JP5327732B2 (ja) * 2007-08-31 2013-10-30 広島県 α−グルコシダーゼ阻害剤及びその製造方法
JPWO2010044371A1 (ja) * 2008-10-16 2012-03-15 国立大学法人群馬大学 インスリン分泌促進剤
RU2553363C2 (ru) * 2009-02-11 2015-06-10 Рамот Ат Тель-Авив Юниверсити Лтд. Антисептические композиции и их применения
IT1396074B1 (it) * 2009-10-12 2012-11-09 Axioma S R L Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita'
EP2559346B1 (en) * 2011-08-15 2014-03-26 Symrise AG Oleanene-type triterpene glycosides as masking agents
CN102920683B (zh) * 2012-06-11 2013-08-14 江苏豪森药业股份有限公司 奥氮平口腔速溶膜
CN104490611B (zh) * 2014-12-12 2017-08-08 安徽新华学院 一种天然养发泡腾颗粒或泡腾片及其制备方法

Also Published As

Publication number Publication date
WO2017084631A9 (zh) 2019-01-17
FI3378481T3 (fi) 2023-07-06
EP3378481B1 (en) 2023-04-05
US20180325840A1 (en) 2018-11-15
CN119424472A (zh) 2025-02-14
EP3378481A1 (en) 2018-09-26
EP3378481A4 (en) 2019-07-10
CN119524140A (zh) 2025-02-28
CN109715170A (zh) 2019-05-03
TW201720461A (zh) 2017-06-16
ES2949047T3 (es) 2023-09-25
WO2017084631A8 (zh) 2018-09-13
HUE062181T2 (hu) 2023-09-28
TWI797068B (zh) 2023-04-01
WO2017084631A1 (zh) 2017-05-26
DK3378481T3 (da) 2023-07-03
PL3378481T3 (pl) 2023-12-27
PT3378481T (pt) 2023-06-28
JP2019511996A (ja) 2019-05-09

Similar Documents

Publication Publication Date Title
JP7429927B2 (ja) 精子の妊孕力増進剤
JP2019514872A5 (enExample)
US12201624B2 (en) Compositions comprising mixtures of compounds and uses thereof
JP2024513567A (ja) １－メチルキサンチンをベースにした生物活性組成物およびそれを使用する方法
CN105920476A (zh) 防治阿尔茨海默病中药组合物及其制备方法
JP6914256B2 (ja) 膵臓脂肪浸潤を予防または治療し、膵臓脂肪浸潤に起因する膵臓病変、糖尿病または他の関連症状を緩和するための組成物、および方法
CN103108639B (zh) 一种中药活性成分组合物及其用途
KR101775087B1 (ko) 멀베로푸란 g, 상게논 g 및 상게놀 a를 유효성분으로 함유하는 스트레스 또는 우울 증상의 개선, 예방 또는 치료용 조성물
KR101368954B1 (ko) 생약추출물을 함유하는 각성효과가 있는 조성물
KR101206543B1 (ko) 율피 추출물을 포함하는 지방간의 예방 또는 치료용 조성물
WO2024164970A1 (en) Administration of dhb to increase benefit of losing weight of intermittent fasting
JPWO2014010658A1 (ja) ヒハツ配合製剤
TWI776450B (zh) 正丁基苯酞於促進脂肪褐變、以及預防或治療脂肪肝及相關肝病變之應用
KR20200082648A (ko) 한약재 지용성 분획 추출물을 유효성분으로 함유하는 천식의 개선, 예방 또는 치료용 조성물
JP6835396B2 (ja) 血中グルコース濃度低減用、血中ヘモグロビンＡ１ｃ量低減用又は血中ＨＤＬ−コレステロール量増加用組成物
JP2008069121A (ja) 脂肪減少促進剤
KR101414040B1 (ko) 누에추출물을 유효성분으로 하는 혈당조절용 약학 조성물, 천연물의약품 및 건강기능식품
KR20210050187A (ko) 썬베르기놀 씨를 유효성분으로 함유하는 스트레스성 질환의 예방 및 치료용 조성물
JP7452777B2 (ja) 生活の質改善又は維持用組成物
CN117979971A (zh) 基于1-甲基黄嘌呤的生物活性组合物及其使用方法
CN120661526A (zh) 一种用于预防和/或改善脑功能障碍的组合物
KR20110117591A (ko) 글루타민을 포함하는 우울증 예방 또는 치료용 조성물
KR20210133890A (ko) 복합 한약재 추출물을 유효성분으로 포함하는 파킨슨병 예방, 치료, 또는 개선용 조성물
CN118340803A (zh) 一种杉叶醇提取物在制备治疗糖尿病药物中的应用
KR20150055456A (ko) 백강잠 추출물을 포함하는 당뇨병 및 당뇨병성 합병증 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191121

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201006

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201224

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210405

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210615

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210713

R150 Certificate of patent or registration of utility model

Ref document number: 6914256

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250